Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-12 Purchase | 2022-01-14 2:13 pm | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 15,000 | $12.6 | $189,000 | 258,885 (Direct) | View |
| 2021-02-12 Purchase | 2021-02-16 6:03 pm | Tishman Speyer Innovation Corp. II | TSIB | Kazam Joshua A Director | 25,000 | $0 | $0 | 30,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-22 Option Award | 2023-06-26 4:09 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Kazam Joshua A Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:56 pm | N/A 2033-06-13 | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 116,120 | $0 | 116,120 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-29 4:08 pm | N/A 2032-06-21 | Kronos Bio Inc. | KRON | Kazam Joshua A Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:58 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 44,178 | $0 | 303,063 (Direct) | View |
| 2022-03-07 Gift | 2022-03-09 6:26 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 412,618 | $0 | 671,503 (Direct) | View |
| 2022-03-07 Other | 2022-03-09 6:26 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 412,618 | $0 | 671,503 (Direct) | View |
| 2022-03-07 Gift | 2022-03-09 4:40 pm | N/A N/A | Kronos Bio Inc. | KRON | Kazam Joshua A Director | 211,000 | $0 | 94,481 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 9:16 pm | N/A 2031-06-21 | Kronos Bio Inc. | KRON | Kazam Joshua A Director | 20,600 | $0 | 20,600 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-11 5:43 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 16,498 | $0 | 243,885 (Direct) | View |
| 2021-06-11 Gift | 2021-06-11 5:43 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 500,000 | $0 | 243,885 (Direct) | View |
| 2021-06-04 Exercise | 2021-06-07 6:39 pm | N/A N/A | TS Innovation Acquisitions Corp. | LTCH | Kazam Joshua A Former Director Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2021-02-11 8:27 pm | N/A N/A | Tishman Speyer Innovation Corp. II | TSIB | Kazam Joshua A Director | 0 | $0 | 30,000 (Direct) | View |
| 2020-10-21 Ownership | 2021-02-03 4:22 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 305,918 | $0 | 727,387 (Direct) | View |
Ownership | 2020-11-09 6:44 pm | N/A N/A | TS Innovation Acquisitions Corp. | TSIA | Kazam Joshua A Director | 0 | $0 | 30,000 (Direct) | View |
| 2020-10-14 Conversion | 2020-10-16 3:47 pm | N/A N/A | Kronos Bio Inc. | KRON | Kazam Joshua A Director | 179,927 | $0 | 94,481 (Direct) | View |
Ownership | 2020-10-08 7:09 pm | N/A N/A | Kronos Bio Inc. | KRON | Kazam Joshua A Director | 0 | $0 | 94,481 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:04 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 9,969 | $0 | 1,033,305 (Direct) | View |
| 2020-04-24 Other | 2020-04-28 4:33 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 8,039 | $0 | 1,031,375 (Direct) | View |
| 2020-03-04 Other | 2020-03-11 4:39 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 8,217 | $0 | 1,023,514 (Direct) | View |
Ownership | 2020-03-05 5:08 pm | N/A N/A | Flying Eagle Acquisition Corp. | FEAC | Kazam Joshua A Director | 0 | $0 | 20,000 (Direct) | View |
| 2019-12-31 Other | 2019-12-31 6:38 pm | N/A N/A | Diamond Eagle Acquisition Corp. | DEAC | Kazam Joshua A Director | 20,000 | $0.0001 | 20,000 (Direct) | View |
| 2019-11-11 Gift | 2019-11-21 4:43 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 446,623 | $0 | 1,015,297 (Direct) | View |
| 2019-11-19 Other | 2019-11-21 4:43 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 8,217 | $0 | 1,015,297 (Direct) | View |
| 2019-10-25 Other | 2019-10-29 8:07 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 8,217 | $0 | 1,453,703 (Direct) | View |
| 2019-09-23 Other | 2019-09-25 6:24 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 8,217 | $0 | 1,445,486 (Direct) | View |
| 2019-09-05 Other | 2019-09-09 6:02 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 8,217 | $0 | 1,437,269 (Direct) | View |
| 2019-07-18 Other | 2019-07-22 4:26 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 8,217 | $0 | 1,429,052 (Direct) | View |
| 2019-07-10 Other | 2019-07-12 5:11 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 5,590 | $0 | 1,418,208 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-24 8:02 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Kazam Joshua A Director | 16,377 | $0 | 1,407,028 (Direct) | View |